Eotaxin and FGF enhance signaling through an extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of Eosinophilic esophagitis.
BACKGROUND
Eosinophilic esophagitis (EoE) is characterized by the inflammation of the esophagus and the infiltration of eosinophils into the esophagus, leading to symptoms such as dysphagia and stricture formation. Systemic immune indicators like eotaxin and fibroblast growth factor were evaluated for possible synergistic pathological effects. Moreover, blood cells, local tissue, and plasma from EoE and control subjects were studied to determine if the localized disease was associated with a systemic effect that correlated with presence of EoE disease.


METHODS
Real-time polymerase chain reaction from peripheral blood mononuclear cells (PBMC), immunohistochemistry from local esophageal biopsies, fluid assays on plasma, and fluorescence-activated cell sorting on peripheral blood cells from subjects were used to study the systemic immune indicators in newly diagnosed EoE (n = 35), treated EoE (n = 9), Gastroesophageal reflux disease (GERD) (n = 8), ulcerative colitis (n = 5), Crohn's disease (n = 5), and healthy controls (n = 8).


RESULTS
Of the transcripts tested for possible immune indicators, we found extracellular signal-regulated kinase (ERK), Bcl-2, bFGF (basic fibroblast growth factor), and eotaxin levels were highly upregulated in PBMC and associated with disease presence of EoE. Increased FGF detected by immunohistochemistry in esophageal tissues and in PBMC was correlated with low levels of pro-apoptotic factors (Fas, Caspase 8) in PBMC from EoE subjects. Plasma-derived bFGF was shown to be the most elevated and most specific in EoE subjects in comparison to healthy controls and disease control subjects.


CONCLUSIONS
We describe for the first time a possible mechanism by which increased FGF is associated with inhibiting apoptosis in local esophageal tissues of EoE subjects as compared to controls. Eotaxin and FGF signaling pathways share activation through the ERK pathway; together, they could act to increase eosinophil activation and prolong the half-life of eosinophils in local tissues of the esophagus in EoE subjects.
Huang
Jennifer J
JJ
Stanford School of Medicine, Stanford, CA 94305, USA.
Joh
Jae Won
JW
Fuentebella
Judy
J
Patel
Anup
A
Nguyen
Tammie
T
Seki
Scott
S
Hoyte
Lisa
L
Reshamwala
Neha
N
Nguyen
Christine
C
Quiros
Anthony
A
Bass
Dorsey
D
Sibley
Eric
E
Berquist
William
W
Cox
Kenneth
K
Kerner
John
J
Nadeau
Kari C
KC
Genome Biol. 2001;2(3):REVIEWS3005
11276432
Dis Esophagus. 2007;20(1):2-8
17227302
J Clin Invest. 2001 Jan;107(1):83-90
11134183
Gastroenterology. 1995 Nov;109(5):1503-12
7557132
Gastrointest Endosc Clin N Am. 2008 Jan;18(1):33-44; viii
18061100
Immunology. 2004 Aug;112(4):605-14
15270732
Clin Gastroenterol Hepatol. 2005 Dec;3(12):1198-206
16361045
Gastroenterology. 2007 Oct;133(4):1342-63
17919504
Clin Exp Allergy. 2005 Aug;35(8):1096-103
16120093
Dermatol Online J. 2006 Jan 27;12(1):2
16638370
Ann Allergy Asthma Immunol. 2007 Mar;98(3):207-14; quiz 214-7, 238
17378251
J Biol Chem. 1996 Nov 22;271(47):29822-9
8939921
J Allergy Clin Immunol. 2001 Feb;107(2):295-301
11174196
FASEB J. 2002 Apr;16(6):598-600
11919166
Gastroenterology. 2009 Oct;137(4):1238-49
19596009
J Pediatr Gastroenterol Nutr. 2007 Sep;45(3):319-28
17873744
N Engl J Med. 2004 Aug 26;351(9):940-1
15329438
Aliment Pharmacol Ther. 2006 Jul 15;24(2):173-82
16842447
J Allergy Clin Immunol. 2003 Oct;112(4):796-7
14564365
Biochem Biophys Res Commun. 2007 Sep 21;361(2):335-41
17662249
Blood. 2000 Mar 15;95(6):1911-7
10706854
J Clin Gastroenterol. 2007 Mar;41(3):252-6
17426462
Gastroenterology. 2003 Nov;125(5):1419-27
14598258
Gut. 2009 Feb;58(2):166-73
18978176
Gastrointest Endosc. 2007 Feb;65(2):335-6
17259000
J Allergy Clin Immunol. 2002 Feb;109(2):363-8
11842310
Am J Pathol. 1997 Dec;151(6):1775-84
9403728